ethylene chlorohydrin has been researched along with Infant, Newborn, Diseases in 1 studies
Ethylene Chlorohydrin: Used as a solvent, in the manufacture of insecticides, and for treating sweet potatoes before planting. May cause nausea, vomiting, pains in head and chest, stupefaction. Irritates mucous membranes and causes kidney and liver degeneration.
chloroethanol : An organochlorine compound that is ethanol substituted by at least one chloro group.
Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chloral hydrate has been used clinically for over 100 years." | 1.28 | Chloral hydrate sedation in neonates and infants--clinical and pharmacologic considerations. ( Gorecki, DK; Hindmarsh, KW; Kasian, GF; Reimche, LD; Sankaran, K; Tan, L, 1989) |
| " Multiple dosing of chloral hydrate in preterm infants should be used with caution and frequent monitoring of serum bilirubin concentrations is indicated in such cases." | 1.28 | Chloral hydrate sedation in neonates and infants--clinical and pharmacologic considerations. ( Gorecki, DK; Hindmarsh, KW; Kasian, GF; Reimche, LD; Sankaran, K; Tan, L, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reimche, LD | 1 |
| Sankaran, K | 1 |
| Hindmarsh, KW | 1 |
| Kasian, GF | 1 |
| Gorecki, DK | 1 |
| Tan, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pharmacotoxicology of Trichloroethylene Metabolites: Short-term Effect of DCA on in Vivo Tyrosine Catabolism and MAAI Expression[NCT00865514] | 2 participants (Actual) | Interventional | 2011-08-31 | Terminated (stopped due to Difficulty in obtaining the solution from the compounding pharmacies caused a two year delay in start-up; the funding ended prior to study completion.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for ethylene chlorohydrin and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Chloral hydrate sedation in neonates and infants--clinical and pharmacologic considerations.
Topics: Bilirubin; Biotransformation; Chloral Hydrate; Ethylene Chlorohydrin; Glucuronates; Humans; Hypnotic | 1989 |